Swiss National Bank’s Catalyst Pharmaceutical CPRX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $4.8M | Buy |
221,300
+13,400
| +6% | +$291K | ﹤0.01% | 1325 |
|
2025
Q1 | $5.04M | Sell |
207,900
-2,200
| -1% | -$53.4K | ﹤0.01% | 1253 |
|
2024
Q4 | $4.38M | Buy |
210,100
+2,500
| +1% | +$52.2K | ﹤0.01% | 1413 |
|
2024
Q3 | $4.13M | Sell |
207,600
-1,200
| -0.6% | -$23.9K | ﹤0.01% | 1448 |
|
2024
Q2 | $3.23M | Hold |
208,800
| – | – | ﹤0.01% | 1549 |
|
2024
Q1 | $3.33M | Buy |
208,800
+19,700
| +10% | +$314K | ﹤0.01% | 1557 |
|
2023
Q4 | $3.18M | Sell |
189,100
-33,400
| -15% | -$561K | ﹤0.01% | 1579 |
|
2023
Q3 | $2.6M | Buy |
222,500
+4,000
| +2% | +$46.8K | ﹤0.01% | 1677 |
|
2023
Q2 | $2.94M | Buy |
218,500
+5,100
| +2% | +$68.5K | ﹤0.01% | 1637 |
|
2023
Q1 | $3.54M | Sell |
213,400
-22,500
| -10% | -$373K | ﹤0.01% | 1475 |
|
2022
Q4 | $4.39M | Buy |
235,900
+4,200
| +2% | +$78.1K | ﹤0.01% | 1400 |
|
2022
Q3 | $2.97M | Hold |
231,700
| – | – | ﹤0.01% | 1599 |
|
2022
Q2 | $1.62M | Hold |
231,700
| – | – | ﹤0.01% | 2064 |
|
2022
Q1 | $1.92M | Buy |
231,700
+14,300
| +7% | +$119K | ﹤0.01% | 2055 |
|
2021
Q4 | $1.47M | Hold |
217,400
| – | – | ﹤0.01% | 2240 |
|
2021
Q3 | $1.15M | Hold |
217,400
| – | – | ﹤0.01% | 2366 |
|
2021
Q2 | $1.25M | Sell |
217,400
-7,600
| -3% | -$43.7K | ﹤0.01% | 2373 |
|
2021
Q1 | $1.04M | Buy |
225,000
+5,700
| +3% | +$26.3K | ﹤0.01% | 2336 |
|
2020
Q4 | $732K | Hold |
219,300
| – | – | ﹤0.01% | 2401 |
|
2020
Q3 | $651K | Hold |
219,300
| – | – | ﹤0.01% | 2289 |
|
2020
Q2 | $1.01M | Buy |
219,300
+39,400
| +22% | +$182K | ﹤0.01% | 2094 |
|
2020
Q1 | $693K | Buy |
179,900
+2,600
| +1% | +$10K | ﹤0.01% | 2022 |
|
2019
Q4 | $665K | Buy |
177,300
+5,200
| +3% | +$19.5K | ﹤0.01% | 2328 |
|
2019
Q3 | $914K | Hold |
172,100
| – | – | ﹤0.01% | 2105 |
|
2019
Q2 | $661K | Buy |
+172,100
| New | +$661K | ﹤0.01% | 2324 |
|